ArticleBMC pediatrics2026
Clinical trajectory and determinants of pulmonary hemorrhage in neonates: a 10-year case-control study.
Article in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPulmonary hemorrhage remains a life-threatening condition in neonates. This study aimed to identify factors associated with pulmonary hemorrhage, characterize the clinical trajectory during the 24 h preceding the event, and evaluate factors associated with mortality.
methodsIn this 10-year single-center case-control study with frequency-matched control selection, neonates with pulmonary hemorrhage were compared with controls matched at the sampling stage according to gestational age, birth weight, and admission period. Perinatal and postnatal variables were analyzed together with clinical characteristics observed during the 24 h preceding pulmonary hemorrhage. Multivariate logistic regression was used to evaluate associations between clinical variables, pulmonary hemorrhage, and mortality. A sensitivity analysis restricted to a recent cohort was performed to assess the robustness of the findings.
resultsA total of 120 neonates (60 cases, 60 controls) were included. Antenatal corticosteroid exposure was associated with a lower likelihood of pulmonary hemorrhage (OR 0.39, 95% CI 0.17-0.93, p = 0.035). Postnatal steroid exposure was associated with pulmonary hemorrhage (OR 4.59, 95% CI 1.01-20.78, p = 0.048). However, this finding likely reflects underlying disease severity, survivor bias, and confounding by indication rather than a direct causal effect. PDA diameter was not independently associated with pulmonary hemorrhage after multivariable adjustment (OR 3.14, 95% CI 0.82-12.07, p = 0.09). Affected neonates frequently exhibited progressive clinical deterioration characterized by increasing ventilatory support requirements, inotropic support, and fluid imbalance during the 24 h preceding pulmonary hemorrhage. Rescue surfactant administration during or shortly after the hemorrhagic episode was associated with mortality among affected neonates (OR 11.20, 95% CI 1.55-80.9, p = 0.017), although this finding should be interpreted cautiously because it may reflect underlying disease severity. Findings were consistent in sensitivity analyses.
conclusionsPulmonary hemorrhage was associated with a recognizable pattern of progressive cardiorespiratory deterioration rather than isolated static clinical characteristics. Increasing respiratory support requirements, hemodynamic instability, and signs of fluid imbalance were common clinical features preceding the hemorrhagic event. These findings highlight a potential period of evolving clinical instability before pulmonary hemorrhage and provide a foundation for future prospective studies aimed at improving risk recognition and clinical monitoring in vulnerable neonates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.